MUC5AC and asthma: Through the augmenter of KC (keratinocyte-derived chemokine) and MIP-2 (macrophage inflammatory protein-2), the asthma-like inflammation, including phenotypic changes like increased inflammatory cells, mucin production, and AHR [25], could be significantly deteriorated.